Dual antiplatelet therapy (DAPT) in post-PCI patients beyond one year

Bibliographic Details
Main Authors:	A.K. Singh, D. Khanra, R. Kumar, S.K. Sinha, A. Merhotra, C.M. Verma
Format:	Article
Language:	English
Published:	Elsevier 2017-11-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483217306399

Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014–2019)
by: A. Mezier, et al.
Published: (2023-03-01)

The effects of dual antiplatelet therapy (DAPT) adherence on survival in patients undergoing revascularization and the determinants of DAPT adherence
by: Shuqi Zhang, et al.
Published: (2022-05-01)

Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
by: Lisa Dannenberg, et al.
Published: (2021-04-01)

Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration.
by: Toshiaki Toyota, et al.
Published: (2017-01-01)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation.
by: Dawid L Staudacher, et al.
Published: (2016-01-01)

Comparison of Short-Term DAPT and Long-Term DAPT on the Prognosis of PCI Patients: A Meta-Analysis of Randomized Controlled Trials
by: Jiaxin Yang, et al.
Published: (2022-09-01)

Triple versus dual antiplatelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) – Our hospital experience
by: Karandeep Singh, et al.
Published: (2015-12-01)

Formal comment to Toyota et al.: Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration.
by: Sammy Elmariah
Published: (2017-01-01)

Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era
by: Kunal Mahajan, et al.
Published: (2020-05-01)

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
by: Pufulete, M, et al.
Published: (2022)

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
by: Barney C Reeves, et al.
Published: (2022-08-01)

Incidence, predictors, and outcomes of DAPT non-compliance in planned vs. ad hoc PCI in chronic coronary syndrome.
by: Jahanzeb Malik, et al.
Published: (2021-01-01)

Performance of PRECISE-DAPT and Age–Bleeding–Organ Dysfunction Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy in Chinese Elderly Patients
by: Liang Dong, et al.
Published: (2022-07-01)

Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI
by: Hao-Yu Wang, et al.
Published: (2021-05-01)

СРАВНЕНИЕ ЭФФЕКТОВ ПРИМЕНЕНИЯ ДВУХКОМПОНЕНТНОЙ АНТИАГРЕГАНТНОЙ ТЕРАПИИ В ТЕЧЕНИЕ ДВЕНАДЦАТИ И ТРИДЦАТИ МЕСЯЦЕВ: РЕЗУЛЬТАТЫ РАНДОМИЗИРОВАННОГО ИССЛЕДОВАНИЯ DAPT (DUAL ANTIPLATELET THERAPY)
Published: (2016-02-01)

Prolonged DAPT following a myocardial infarction: Is there a role for the DAPT score?
by: Dimitrios Alexopoulos
Published: (2019-09-01)

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
by: Yong-zhe Guo, et al.
Published: (2021-08-01)

Long‐Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second‐Generation Drug‐Eluting Stents: The Veterans Affairs Extended DAPT Study
by: Scott Kinlay, et al.
Published: (2023-01-01)

Incidence of mace with genotype test guided antiplatelet treatment strategy after PCI
by: S. Ramesh, et al.
Published: (2015-12-01)

Association Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study
by: Kamil F. Faridi, et al.
Published: (2023-07-01)

Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks
by: Yong Zhang, et al.
Published: (2023-02-01)

Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
by: Solheim Svein, et al.
Published: (2013-01-01)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01)

Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
by: Abdullah M. Al-Rubaish, et al.
Published: (2020-06-01)

Antiplatelet Therapy in High-Bleeding Risk Patients Undergoing PCI: Walking a Tightrope
by: Davis Jones, et al.
Published: (2022-06-01)

Abstract 114: “Failing” DAPT? Think Again
by: Ankita Brahmaroutu, et al.
Published: (2023-11-01)

Double Trouble: Interrupting DAPT and COVID-19
by: Mihăilă Theofana, et al.
Published: (2022-06-01)

Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI
by: Hao-Yu Wang, et al.
Published: (2020-07-01)

Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating ‘target trials’ (the ADAPTT Study)
by: Chris A Rogers, et al.
Published: (2019-06-01)

Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating ‘target trials’ (the ADAPTT Study)
by: Pufulete, M, et al.
Published: (2019)

A comparison of safety and efficacy between long-term DAPT and intensive statins combined with short-term DAPT for acute ischemic stroke
by: Ting Deng, et al.
Published: (2023-04-01)

DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation
by: Mauro Di Bari, et al.
Published: (2018-06-01)

PCI Relaxation Vest: Rompi Terapi untuk Pasien Post PCI
by: Rizky Rayhan Najib Soamangon, et al.
Published: (2024-04-01)

Comparing efficacy of antiplatelet agents in PCI patients heterozygous to CYP2C19*2/*3 mutations
by: S. Ramesh, et al.
Published: (2015-12-01)

PCI post-tensioning manual /
by: 4653 Prestressed Concrete Institute (United States)
Published: (1972)

Age and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: a post hoc analysis of the randomized PATH-PCI trial
by: Ying Pan, et al.
Published: (2023-12-01)

DURATION OF DUAL ANTIPLATELET THERAPY
by: O. L. Barbarash
Published: (2016-07-01)

Short Versus Long-Term Dual Antiplatelet Therapy in Patients at High Bleeding Risk Undergoing PCI in Contemporary Practice: A Systemic Review and Meta-analysis
by: Nader Mankerious, et al.
Published: (2023-06-01)

DAPT: A package enabling distributed automated parameter testing
by: Ben Duggan, et al.
Published: (2021-06-01)

Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome
by: Clara Bonanad, et al.
Published: (2022-03-01)

Dual antiplatelet therapy (DAPT) in post-PCI patients beyond one year

Similar Items

Similar Items